Dipna Pharmachem Limited (BOM:543594)
8.88
+0.38 (4.47%)
At close: Mar 10, 2026
Dipna Pharmachem Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 6.92 | 4.26 | 138.78 | 56.92 | 2.09 | 2.53 | Upgrade
|
| Short-Term Investments | - | 6.83 | 10.16 | 2.48 | - | - | Upgrade
|
| Cash & Short-Term Investments | 6.92 | 11.08 | 148.94 | 59.4 | 2.09 | 2.53 | Upgrade
|
| Cash Growth | 3341.29% | -92.56% | 150.73% | 2746.89% | -17.59% | 42.17% | Upgrade
|
| Accounts Receivable | 568.76 | 462.76 | 309.37 | 285.32 | 269.75 | 149.48 | Upgrade
|
| Receivables | 568.76 | 1,017 | 752.36 | 511.41 | 269.85 | 167.2 | Upgrade
|
| Inventory | 344.86 | 274.35 | 373.82 | 189.43 | 63.04 | 71.95 | Upgrade
|
| Other Current Assets | 853.72 | 20.74 | 53.54 | 14.95 | 26.91 | 5.84 | Upgrade
|
| Total Current Assets | 1,774 | 1,323 | 1,329 | 775.2 | 361.88 | 247.53 | Upgrade
|
| Property, Plant & Equipment | 0.47 | 0.46 | 0.37 | 0.4 | 0.41 | 0.41 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.03 | 0.03 | 0.03 | 0.01 | - | - | Upgrade
|
| Other Long-Term Assets | - | - | - | -0 | - | - | Upgrade
|
| Total Assets | 1,775 | 1,324 | 1,329 | 775.6 | 362.3 | 247.93 | Upgrade
|
| Accounts Payable | 894.95 | 658.43 | 706.46 | 352.39 | 230.3 | 117.79 | Upgrade
|
| Accrued Expenses | - | - | - | - | 8.7 | 0.04 | Upgrade
|
| Short-Term Debt | - | - | 1 | - | 43.91 | 87.42 | Upgrade
|
| Current Portion of Long-Term Debt | 32.58 | 83.33 | 67.98 | 49.38 | - | - | Upgrade
|
| Current Income Taxes Payable | 10.38 | 5.42 | 12.09 | 8.73 | 4.03 | 0.13 | Upgrade
|
| Current Unearned Revenue | - | 98.82 | 38.9 | 10.44 | - | - | Upgrade
|
| Other Current Liabilities | 142.7 | 3.97 | 1.98 | 1.39 | - | - | Upgrade
|
| Total Current Liabilities | 1,081 | 849.96 | 828.4 | 422.32 | 286.93 | 205.37 | Upgrade
|
| Long-Term Debt | 105.3 | 88.9 | 125.47 | 109.69 | 57.98 | 36.84 | Upgrade
|
| Other Long-Term Liabilities | -0 | - | -0 | -0 | - | - | Upgrade
|
| Total Liabilities | 1,186 | 938.86 | 953.87 | 532.02 | 344.91 | 242.22 | Upgrade
|
| Common Stock | 240.45 | 240.45 | 240.45 | 119.7 | 0.35 | 0.35 | Upgrade
|
| Additional Paid-In Capital | - | 113.26 | 113.26 | 113.26 | 2.25 | 2.25 | Upgrade
|
| Retained Earnings | - | 31.22 | 21.48 | 10.63 | 14.79 | 3.12 | Upgrade
|
| Shareholders' Equity | 588.86 | 384.93 | 375.19 | 243.58 | 17.39 | 5.72 | Upgrade
|
| Total Liabilities & Equity | 1,775 | 1,324 | 1,329 | 775.6 | 362.3 | 247.93 | Upgrade
|
| Total Debt | 137.88 | 172.23 | 194.45 | 159.08 | 101.89 | 124.26 | Upgrade
|
| Net Cash (Debt) | -130.96 | -161.15 | -45.51 | -99.67 | -99.8 | -121.73 | Upgrade
|
| Net Cash Per Share | -5.53 | -6.78 | -3.77 | -8.31 | -594.06 | -724.60 | Upgrade
|
| Filing Date Shares Outstanding | 23.92 | 24.05 | 24.05 | 11.97 | 7.97 | 0.17 | Upgrade
|
| Total Common Shares Outstanding | 23.92 | 24.05 | 24.05 | 11.97 | 0.17 | 0.17 | Upgrade
|
| Working Capital | 693.65 | 473.34 | 500.26 | 352.87 | 74.95 | 42.15 | Upgrade
|
| Book Value Per Share | 24.62 | 16.01 | 15.60 | 20.35 | 103.48 | 34.03 | Upgrade
|
| Tangible Book Value | 588.86 | 384.93 | 375.19 | 243.58 | 17.39 | 5.72 | Upgrade
|
| Tangible Book Value Per Share | 24.62 | 16.01 | 15.60 | 20.35 | 103.48 | 34.03 | Upgrade
|
| Machinery | - | 1.24 | 1.04 | 0.89 | 0.79 | 0.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.